-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Opening Remarks

Symposia: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation Program: Scientific Workshops
Friday, December 6, 2024: 2:00 PM-2:05 PM
Room 4 (San Diego Convention Center)
Moderators:
Uma Borate, MD, The Ohio State University and Stephanie Valerie Seremetis, MD, Novo Nordisk
Disclosures:
Borate: Beigene: Membership on an entity's Board of Directors or advisory committees; Vincerx Pharma: Membership on an entity's Board of Directors or advisory committees; BMS: Consultancy; Takeda: Other: IDMC; Incyte: Consultancy; Daiichi Sankyo: Consultancy; Sumitomo: Consultancy; Rigel: Consultancy; Astellas: Consultancy; Abbvie: Consultancy; Novartis: Consultancy. Seremetis: TEVA: Current equity holder in publicly-traded company; Novo Nordisk: Current Employment, Current equity holder in publicly-traded company.

Uma Borate, MD

The Ohio State University, Columbus, OH

Stephanie Valerie Seremetis, MD

Novo Nordisk, Plainsboro, NC